These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 693104)

  • 1. [Experience with the use of native anti-rhesus immunoglobulin for prevention of hemolytic disease of the newborn].
    Timoshenko LV; Khilobok VI; Gamachek IK; Gorobets EI; Komarova SI
    Pediatr Akus Ginekol; 1978; (4):41-2. PubMed ID: 693104
    [No Abstract]   [Full Text] [Related]  

  • 2. [Administration of anti-D-gamma globulin in the prevention of hemolytic disease of the newborn].
    Mrázová M; Valnícek S; Vacl J
    Cesk Gynekol; 1972 May; 37(4):236-7. PubMed ID: 5027209
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prevention of Rhesus sensitization using anti-D, ten years after initiation of the first studies].
    Schneider J
    Z Geburtshilfe Perinatol; 1972 Feb; 176(1):2-16. PubMed ID: 4553933
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prevention of Rhesus-sensitization by intravenous administration of immunoglobulin G anti-D. II. General prevention using low doses of IgG anti-D, adapted to the extent of fetomaternal transfusion].
    Börner P; Deicher H; Ghani G; Geldmacher H; Kayser D; Kahnt P; Klang D; Klaus H; Marks V; Nehawandian OA
    Geburtshilfe Frauenheilkd; 1971 Oct; 31(10):911-23. PubMed ID: 5002413
    [No Abstract]   [Full Text] [Related]  

  • 5. [Selective prevention of Rhesus iso-immunization using anti-D immunoglobulin: our initial results].
    Schlaeder G; Kuhn A; Gandar R
    Rev Fr Gynecol Obstet; 1969 Jun; 64(6):321-3. PubMed ID: 4998210
    [No Abstract]   [Full Text] [Related]  

  • 6. [Problem of the dose of immunoglobulins in the prevention of hemolytic disease of newborn due to materno-fetal incompatibility of antigen D, in case of massive feto-maternal hemorrhage].
    Mattone PG; Meriggi E; De Martin G
    Minerva Ginecol; 1972 May; 24(7):337-41. PubMed ID: 4211573
    [No Abstract]   [Full Text] [Related]  

  • 7. [Intensive plasma exchange for the prevention of hemolytic disease of the newborn caused by anti-Rhesus alloimmunization].
    Dupont E; Lambermont M; Thayse C; Gammar N; Vanherweghem JL; Rodesh F; Schwers J; Wybran J
    Rev Med Brux; 1983 Dec; 4(10):663-6. PubMed ID: 6658250
    [No Abstract]   [Full Text] [Related]  

  • 8. [Our preliminary experience in the field of serum prevention of anti-HDN hemolytic disease of the newborn by means of anti-D immunoglobulins].
    Arrotta U; Cardinale F; Sideri L
    Minerva Ginecol; 1972 Dec; 24(12):619-26. PubMed ID: 4211544
    [No Abstract]   [Full Text] [Related]  

  • 9. [The Kleihauer test and directed prevention of hemolytic disease of the newborn caused by materno-fetal Rh isoimmunization].
    De Luca P; Adinolfi G; Corbo M
    Arch Ostet Ginecol; 1980; 85(5):481-94. PubMed ID: 6807269
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prevention of hemolytic disease of the newborn by use of anti-rhesus (D) immunoglobulin].
    Borst-Eilers E
    Ned Tijdschr Verloskd Gynaecol; 1969 Oct; 69(5):383-91. PubMed ID: 4186579
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical experience with prevention of isoimmunization by means of IgC gamma globulin].
    Kronus R; Kulich V; Veselý J
    Cesk Gynekol; 1971 Oct; 36(8):484-6. PubMed ID: 5000925
    [No Abstract]   [Full Text] [Related]  

  • 12. [Activity of the Center for study of Rh factors of the Clinica Ostetrica e Ginecologica of the University of Naples in the prevention of hemolytic disease of the newborn].
    Paladini A; Di Martino D; De Luca P; Rascio B; Di Lieto A
    Arch Ostet Ginecol; 1969 Dec; 74(6):461-75. PubMed ID: 5406384
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunosuppressive mechanism and effect of immunoglobulins Anti D and Anti DK (IgG) in the prevention of hemolytic disease of the newborn caused by Rh incompatibility].
    Skrzypulec ZA
    Zentralbl Gynakol; 1973 Mar; 95(12):402-10. PubMed ID: 4634158
    [No Abstract]   [Full Text] [Related]  

  • 14. Rh hemolytic disease of the newborn: its cause and prevention.
    Pollack W
    Prog Clin Biol Res; 1981; 70():185-302. PubMed ID: 6273932
    [No Abstract]   [Full Text] [Related]  

  • 15. [Mode of action of immunoprevention in anti-Rh-induced haemolytic disease of newborn infants].
    Schubert W; Tesar V
    Dtsch Gesundheitsw; 1972 Nov; 27(47):2243-5. PubMed ID: 4662688
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunosuppressive mechanism and effect of immunoglobulins anti D (IgG) in prevention of primary Rhesus sensitization].
    Skrzypulec Z
    Zentralbl Gynakol; 1972 Feb; 94(6):196-8. PubMed ID: 5023017
    [No Abstract]   [Full Text] [Related]  

  • 17. [Preliminary results of the use of anti-D immuno-gamma-globulin in the prevention of Rh factor isoimmunization].
    Gherardi A
    Ig Mod; 1970; 63(1):47-56. PubMed ID: 4991878
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prevention of an Rh serological incompatibility].
    Seyfriedowa H
    Pieleg Polozna; 1980; (5):16-7. PubMed ID: 6902385
    [No Abstract]   [Full Text] [Related]  

  • 19. [Our preliminary experience with prevention of Rh hemolytic disease of the newborn by routine use of anti-D IgG].
    Foti A; Volpe L
    Minerva Ginecol; 1976 Jun; 28(6):502-5. PubMed ID: 828247
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prevention of hemolytic disease of the newborn by anti-D immunoglobulins. Practical problems].
    Devant J; Chatelain P
    Rev Fr Transfus; 1970 Sep; 13(3):309-17. PubMed ID: 5533946
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.